A new Russian review in IJMS shows how SARS-CoV-2 reshapes the epigenome - weaving together known mechanisms into something deeper.
It’s not just long COVID.
It’s a virus that rewrites the factory that makes immune cells - the bone marrow🧵
Zolotarenko puts special emphasis on this point.
The changes don’t appear in mature immune cells -
they start in their progenitors.
These hematopoietic precursors are born misprogrammed inside the marrow.
That’s why, even after infection clears, the body keeps producing confused immune cells.
The virus is gone, but its instructions remain.
An epigenetic imprint continues to guide new cells months later.
Key points:
The immune imprint in bone marrow.
Cytokines like IL-6, TNF, and GM-CSF don’t stay in the blood.
They penetrate the marrow and rewrite the genetic instructions of stem cells.
IL-6 acts as an epigenetic recorder.
It modifies DNA methylation and histone marks in hematopoietic stem cells (HSPCs).
The marrow remembers the infection
and keeps making hyper-reactive cells long after the virus is gone.
ORF8 - the virus with a key to our DNA.
SARS-CoV-2 reaches deep into the nucleus.
Its ORF8 protein mimics a human histone (H3) and changes which genes can be read.
It doesn’t destroy DNA - it rewrites access permissions.
That silences interferon pathways from within -
the virus stays, but the alarms go quiet.
It’s a pattern we know from latent viruses like EBV or CMV.
SARS-CoV-2 may not hide, but it lingers through memory.
Epigenetic aging.
After infection, cellular epigenetic clocks speed up.
Cells behave as if they’re older -
more inflammation, slower repair, less resilience.
The rhythm is lost.
The immune system overreacts when it should rest,
and stays silent when it should defend.
It’s aging not by years, but by how cells interpret their own code.
The N protein – a quiet remodeler of DNA
Protein N binds to chromatin and shifts nucleosomes - the anchors that organize DNA.
That changes which genes stay open and which fall silent.
It touches genes for immunity, coagulation, and vascular stability.
Imagine someone moving chapters in a book -
the words are the same, but the story changes.
Result - microclots, fatigue, barrier damage.
miRNA.
Cells regulate balance using small RNAs - miRNAs.
During COVID, many are lost.
Inflammatory circuits stay on, as if the car lost its brakes.
Meanwhile, the virus makes its own miRNA-like fragments that mimic ours.
They silence key antiviral genes (IRF7, BATF2).
The body hears the alarm - but no one picks up the phone.
Inflammation runs on, even without virus.
Can the epigenome be erased?
Epigenetic change has one advantage - it’s reversible.
Zolotarenko discusses epigenetic reversion -
resetting cell programs using so-called epidrugs.
HDAC and DNMT inhibitors, already in cancer and neuro research,
don’t attack the virus but the imprint it leaves behind.
The goal isn’t to kill the virus - it’s to rehabilitate cellular memory.
IL-6.
In the acute phase, IL-6 protects.
But if it lingers, it starts writing to memory.
It alters DNA methylation and histone profiles in bone marrow.
A short-term defense becomes a long-term rewrite.
IL-6 as a molecular chronicler of infection.
What it records during fever can echo for months.
Block it too early - you hinder defense.
Block it too late - you risk embedding the imprint.
Sum:
COVID-19 is not an ordinary infection.
It’s a virus that reaches the body’s command layer - the epigenome -
and rewires how immunity forms and behaves.
Zolotarenko puts it clearly.
SARS-CoV-2 leaves an epigenetic latency.
It doesn’t stay active -
but the body keeps carrying its instructions.
New cells are born already carrying the memory of infection.
Unlike typical viruses that visit and leave,
COVID-19 acts like an architect -
it redraws the blueprint of the house and walks away before we notice.
Biologically, we’ve seen similar outcomes with other latent viruses
immune deregulation
altered responses to new infections
higher risk of autoimmunity and some cancers.
Zolotarenko et al., COVID-19 Hijacking of the Host Epigenome: Mechanisms, Biomarkers and Long-Term Consequences. International Journal of Molecular Sciences, 2025. mdpi.com/1422-0067/26/2…
Repeated SARS-CoV-2 infections mean repeated hits to the immune and epigenetic systems.
When a virus rewires how our cells read their own DNA, it’s not just a personal issue but population biology.
These long-term shifts deserve public health monitoring.
This isn’t alarmism - it’s realism.
COVID-19 isn’t a brief episode, but a virus with a long shadow.
And to understand its legacy,
we must learn to read the language it left inside our immune system.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A new important study in Frontiers in Immunology shows that repeated SARS-CoV-2 infections are beginning to display the same patterns seen in chronic viral infections - narrowing of the T-cell repertoire, exhaustion, and loss of immune flexibility (!)🧵
The immune repertoire doesn’t fully recover after infection. Diversity shrinks, and with reinfection the system no longer returns to balance.
The study analyzed T-cell receptors in people after a first infection and after reinfection with SARS-CoV-2.
The result?
Reinfection isn’t just another infection - it leaves a measurable imprint on the immune system.
A study from Krakow followed hospitalized COVID-19 patients for five years to see if their initial immune profiles - T, B, and NK cells - could predict who would
die in the following years, or develop long COVID.🧵
Out of 103 patients from 2020, researchers followed 80 over 54 months.
23 had died, 57 were alive - and about half of those survivors (29 people) still lived with long COVID symptoms.
That’s one of the longest immune follow-ups after COVID-19 so far.
During the acute infection, those with severe disease showed a collapse of T and NK cells.
Their total T cells dropped to a median of 340 per µl (vs 705 in milder cases).
CD4+ helper T cells fell to 183 vs 452, and CD8+ cytotoxic T cells to 109 vs 227.
Even NK cells were lower (107 vs 157).
Meanwhile, the proportion of B cells was paradoxically higher - 18.5% vs 12.5%.
A new preprint from Aarhus University shows something striking:
people with post-COVID, MCS, and functional disorders all share the same brain pattern -
split hemispheres, weakened bridges between left and right (!),
overloaded smell and sensory circuits🧵
The study scanned 57 women (post-COVID, MCS, FSD, controls) using diffusion MRI (DTI).
It didn’t measure brain activity, but rather its wiring - the white-matter highways that carry information between regions.
Result.
Interhemispheric connectivity - the bridge between left and right hemispheres - was reduced by 70% in all three patient groups.
That means information flow across the brain is slower, less coordinated, and less efficient.
A new study strengthens the view that SARS-CoV-2:
disrupts brain homeostasis,
alters ionic & neurotransmitter balance,
and triggers lasting epigenetic reprogramming.
Researchers exposed human primary astrocytes to Delta and Omicron.
The results are striking🧵
Astrocytes were infected with Delta and Omicron at a very low viral load (MOI 0.2).
After just 6 hours, RNA-seq revealed major transcriptional shifts
Omicron deregulated 346 genes (197 ↑, 149 ↓)
Delta deregulated 341 (215 ↑, 126 ↓)
About half of the changes overlapped.
Even minimal exposure triggered broad molecular changes within hours.
Viral sensing and immune response.
Astrocytes primarily activated TLR2, but not RIG-I or NLRP3 - meaning they sensed the virus without launching a full antiviral storm.
Only 16 genes involved in interferon and interleukin signaling were affected.
Even though Omicron often causes milder illness, it leaves a clear metabolic footprint disrupting liver, immune, and energy metabolism.
A new study shows that even 2-4 weeks after recovery, the body does not return to normal metabolic state🧵
Researchers analyzed blood serum from 300 Omicron patients, 200 recovered, and 380 healthy controls.
Using LC-MS metabolomics, they tracked hundreds of molecules revealing how the infection affects the liver, mitochondria, and immune system.
Over 100 metabolites were significantly altered during infection - that’s expected in any acute illness.
What’s not expected?
Most of these changes did not return to normal even after clinical recovery.
For the first time ever, a human body was instructed to make lab-designed antibodies against SARS-CoV-2 - by itself - from synthetic DNA.
One shot.
No virus.
Protection lasting over a year.🧵
A new Nature Medicine study tested something called DNA-encoded monoclonal antibodies (DMAbs).
Instead of injecting ready made antibodies, scientists injected synthetic DNA that tells your cells how to make them.
Your muscle becomes a mini factory for antibodies.
The DNA carried blueprints for tixagevimab and cilgavimab - the antibodies used in Evusheld.
It was delivered intramuscularly, with short electric pulses (electroporation) that help DNA enter cells.